Menu
GeneBe

rs200567140

Variant summary

Our verdict is Likely benign. Variant got -6 ACMG points: 3P and 9B. PM2PP2BP4_StrongBP6BS1

The NM_015192.4(PLCB1):c.724G>A(p.Val242Ile) variant causes a missense change. The variant allele was found at a frequency of 0.000112 in 1,610,192 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).

Frequency

Genomes: 𝑓 0.00013 ( 0 hom., cov: 32)
Exomes 𝑓: 0.00011 ( 1 hom. )

Consequence

PLCB1
NM_015192.4 missense

Scores

5
8

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:2B:1

Conservation

PhyloP100: 4.79
Variant links:
Genes affected
PLCB1 (HGNC:15917): (phospholipase C beta 1) The protein encoded by this gene catalyzes the formation of inositol 1,4,5-trisphosphate and diacylglycerol from phosphatidylinositol 4,5-bisphosphate. This reaction uses calcium as a cofactor and plays an important role in the intracellular transduction of many extracellular signals. This gene is activated by two G-protein alpha subunits, alpha-q and alpha-11. Two transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jul 2008]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Likely_benign. Variant got -6 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
PP2
Missense variant where missense usually causes diseases, PLCB1
BP4
Computational evidence support a benign effect (MetaRNN=0.010023236).
BP6
Variant 20-8658566-G-A is Benign according to our data. Variant chr20-8658566-G-A is described in ClinVar as [Conflicting_classifications_of_pathogenicity]. Clinvar id is 339500.We mark this variant Likely_benign, oryginal submissions are: {Likely_benign=1, Uncertain_significance=2}.
BS1
Variant frequency is greater than expected in population amr. gnomad4 allele frequency = 0.000131 (20/152122) while in subpopulation AMR AF= 0.000655 (10/15270). AF 95% confidence interval is 0.000354. There are 0 homozygotes in gnomad4. There are 10 alleles in male gnomad4 subpopulation. This position pass quality control queck.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE UniProt
PLCB1NM_015192.4 linkuse as main transcriptc.724G>A p.Val242Ile missense_variant 9/32 ENST00000338037.11
PLCB1NM_182734.3 linkuse as main transcriptc.724G>A p.Val242Ile missense_variant 9/33

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Appris UniProt
PLCB1ENST00000338037.11 linkuse as main transcriptc.724G>A p.Val242Ile missense_variant 9/321 NM_015192.4 P1Q9NQ66-1

Frequencies

GnomAD3 genomes
AF:
0.000132
AC:
20
AN:
152004
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0000967
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000656
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.000578
Gnomad SAS
AF:
0.000207
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000294
Gnomad OTH
AF:
0.00
GnomAD3 exomes
AF:
0.000545
AC:
135
AN:
247754
Hom.:
1
AF XY:
0.000404
AC XY:
54
AN XY:
133822
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.00316
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.000440
Gnomad SAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000445
Gnomad OTH exome
AF:
0.00250
GnomAD4 exome
AF:
0.000110
AC:
160
AN:
1458070
Hom.:
1
Cov.:
30
AF XY:
0.0000882
AC XY:
64
AN XY:
725244
show subpopulations
Gnomad4 AFR exome
AF:
0.0000603
Gnomad4 AMR exome
AF:
0.00277
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.000126
Gnomad4 SAS exome
AF:
0.0000117
Gnomad4 FIN exome
AF:
0.00
Gnomad4 NFE exome
AF:
0.0000189
Gnomad4 OTH exome
AF:
0.000133
GnomAD4 genome
AF:
0.000131
AC:
20
AN:
152122
Hom.:
0
Cov.:
32
AF XY:
0.000134
AC XY:
10
AN XY:
74362
show subpopulations
Gnomad4 AFR
AF:
0.0000964
Gnomad4 AMR
AF:
0.000655
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.000580
Gnomad4 SAS
AF:
0.000208
Gnomad4 FIN
AF:
0.00
Gnomad4 NFE
AF:
0.0000294
Gnomad4 OTH
AF:
0.00
Alfa
AF:
0.0000623
Hom.:
0
Bravo
AF:
0.000287
ExAC
AF:
0.000651
AC:
79
Asia WGS
AF:
0.000289
AC:
1
AN:
3478
EpiCase
AF:
0.0000546
EpiControl
AF:
0.0000596

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:2Benign:1
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

Developmental and epileptic encephalopathy, 12 Uncertain:1Benign:1
Likely benign, criteria provided, single submitterclinical testingInvitaeDec 03, 2023- -
Uncertain significance, criteria provided, single submitterclinical testingIllumina Laboratory Services, IlluminaJan 12, 2018This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score, this variant could not be ruled out of causing disease and therefore its association with disease required further investigation. A literature search was performed for the gene, cDNA change, and amino acid change (if applicable). No publications were found based on this search. This variant was therefore classified as a variant of unknown significance for this disease. -
Inborn genetic diseases Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingAmbry GeneticsNov 27, 2018The p.V242I variant (also known as c.724G>A), located in coding exon 9 of the PLCB1 gene, results from a G to A substitution at nucleotide position 724. The valine at codon 242 is replaced by isoleucine, an amino acid with highly similar properties. This amino acid position is well conserved in available vertebrate species. In addition, this alteration is predicted to be tolerated by in silico analysis. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.078
BayesDel_addAF
Benign
-0.49
T
BayesDel_noAF
Benign
-0.48
Cadd
Pathogenic
28
Dann
Uncertain
0.99
Eigen
Uncertain
0.39
Eigen_PC
Uncertain
0.49
FATHMM_MKL
Uncertain
0.95
D
LIST_S2
Benign
0.84
T;T;.;T;T;T;T;T
M_CAP
Benign
0.0077
T
MetaRNN
Benign
0.010
T;T;T;T;T;T;T;T
MetaSVM
Benign
-1.2
T
MutationTaster
Benign
1.0
D;D;D
PrimateAI
Uncertain
0.64
T
Polyphen
0.99, 0.31
.;.;D;B;D;.;.;.
Vest4
0.32, 0.33
MVP
0.41
MPC
0.92
ClinPred
0.025
T
GERP RS
6.0
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.7
Varity_R
0.23
gMVP
0.20

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.030
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs200567140; hg19: chr20-8639213; COSMIC: COSV62041112; COSMIC: COSV62041112; API